PATENT CLAIM ANALYSIS

Application Number: 16179050
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["540", "555000"]

Abstract:
The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT 2C  receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT 2C  receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT 2C  receptor.

Claim (Index 25):
The compound as claimed in  claim 22 , where\n R 7  and R 8 , independently of each other, are selected from halogen, cyano, C 1 -C 6 -alkyl, fluorinated C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, fluorinated C 1 -C 6 -alkoxy, phenyl, phenyl-C 1 -C 2 -alkyl, benzyloxy and a 3-, 4-, 5- or 6-membered saturated, partially unsaturated or maximally unsaturated ring containing 1, 2, 3 or 4 heteroatoms or heteroatom groups independently selected from N, O, S, NO, SO, SO 2 , C\u2550O and C\u2550S as ring members, where the cyclic moieties in the four last-mentioned radicals may be substituted with one or more substituents R 11 ; or R 7  and R 8 , together with the carbon atom they are bound to, form a 3-, 4-, 5-, 6- or 7- or 8-membered saturated, partially unsaturated or maximally unsaturated ring, where the ring may contain 1, 2, 3 or 4 heteroatoms or heteroatom-containing groups selected from O, S, N, SO, SO 2 , C\u2550O and C\u2550S as ring members, and where the ring may be substituted with one or more substituents R 11 ; or R 5a  and R 7 , together with the carbon atoms they are bound to, form a 3-, 4-, 5-, 6- or 7-membered saturated, partially unsaturated or maximally unsaturated ring, where the ring may contain 1, 2, 3 or 4 heteroatoms or heteroatom-containing groups selected from O, S, N, SO, SO 2 , C\u2550O and C\u2550S as ring members, and where the ring may be substituted with one or more substituents R 11 ; in which case R 8  has one of the above meanings or is deuterium; and R 5b  is selected from hydrogen and deuterium.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 98.0
- Lexical Diversity: 1.88636
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13838788', '14657840', '14657916', '14026354', '14868835']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7324614089063429
- 35 USC 102 Novelty (BERT): 0.6099829900875778
- Combined Prediction Score: 0.7202135670244664
- Mean Citation Score: 483.115398
- Max Citation Score: 558.0024
- Similarity Product: 455.8932333675385

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test